Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) General Information

Description

Intellectual property and exclusive global rights to develop and commercialise a carbonic anhydrase inhibitor located in Hamburg, Germany.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Hamburg
  • Germany
Primary Industry
Buildings and Property
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Acquirer
Corporate Office
  • Hamburg
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame)‘s full profile, request access.

Request a free trial

Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame)‘s full profile, request access.

Request a free trial

Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) FAQs

  • Where is Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) headquartered?

    Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) is headquartered in Hamburg, Germany.

  • What industry is Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) in?

    Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame)’s primary industry is Buildings and Property.

  • Is Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) a private or public company?

    Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) is a Private company.

  • What is Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame)’s current revenue?

    The current revenue for Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) is .

  • Who are Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame)’s investors?

    Desitin Arzneimittel has invested in Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame).

  • When was Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) acquired?

    Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) was acquired on 23-Apr-2025.

  • Who acquired Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame)?

    Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) was acquired by Apnimed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process